153 related articles for article (PubMed ID: 37368235)
1. Intrinsic and Effective Severity of Coronavirus Disease 2019 Cases Infected With the Ancestral Strain and Omicron BA.2 Variant in Hong Kong.
Wong JY; Cheung JK; Lin Y; Bond HS; Lau EHY; Ip DKM; Cowling BJ; Wu P
J Infect Dis; 2023 Nov; 228(9):1231-1239. PubMed ID: 37368235
[TBL] [Abstract][Full Text] [Related]
2. Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study.
Lin Y; Wu P; Tsang TK; Wong JY; Lau EHY; Yang B; Leung GM; Cowling BJ
Lancet Microbe; 2023 Sep; 4(9):e722-e731. PubMed ID: 37659420
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January-March 2022.
Mefsin YM; Chen D; Bond HS; Lin Y; Cheung JK; Wong JY; Ali ST; Lau EHY; Wu P; Leung GM; Cowling BJ
Emerg Infect Dis; 2022 Sep; 28(9):1856-1858. PubMed ID: 35914518
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
[TBL] [Abstract][Full Text] [Related]
5. Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022.
Chen X; Yan X; Sun K; Zheng N; Sun R; Zhou J; Deng X; Zhuang T; Cai J; Zhang J; Ajelli M; Yu H
medRxiv; 2022 Jul; ():. PubMed ID: 35898339
[TBL] [Abstract][Full Text] [Related]
6. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.
Mok CKP; Chen C; Zhao S; Sun Y; Yiu K; Chan TO; Lai HL; Lai KC; Lau KM; Ling KC; Chan KKP; Ng SS; Ko FW; Peiris M; Hui DS
Lancet Microbe; 2023 Jun; 4(6):e418-e430. PubMed ID: 37086735
[TBL] [Abstract][Full Text] [Related]
7. Air dispersal of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Implications for hospital infection control during the fifth wave of coronavirus disease 2019 (COVID-19) due to the SARS-CoV-2 omicron variant in Hong Kong.
Wong SC; Chan VW; Yuen LL; AuYeung CH; Leung JO; Li CK; Kwok MO; So SY; Chen JH; Tam AR; Hung IF; To KK; Lo JY; Yuen KY; Cheng VC
Infect Control Hosp Epidemiol; 2023 Aug; 44(8):1321-1324. PubMed ID: 36278515
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of BNT162b2 and Sinovac vaccines against the transmission of SARS-CoV-2 during Omicron-predominance in Hong Kong: A retrospective cohort study of COVID-19 cases.
Zhao S; Guo Z; Sun S; Hung CT; Leung EYM; Wei Y; Wang H; Li K; Yam CHK; Chow TY; Gao J; Jia KM; Chong KC; Yeoh EK
J Clin Virol; 2023 Sep; 166():105547. PubMed ID: 37453162
[TBL] [Abstract][Full Text] [Related]
9. Estimating the serial intervals of SARS-CoV-2 Omicron BA.4, BA.5, and BA.2.12.1 variants in Hong Kong.
Guo Z; Zhao S; Yam CHK; Li C; Jiang X; Chow TY; Chong KC; Yeoh EK
Influenza Other Respir Viruses; 2023 Feb; 17(2):e13105. PubMed ID: 36824395
[TBL] [Abstract][Full Text] [Related]
10. Comparison of control and transmission of COVID-19 across epidemic waves in Hong Kong: an observational study.
Yang B; Lin Y; Xiong W; Liu C; Gao H; Ho F; Zhou J; Zhang R; Wong JY; Cheung JK; Lau EHY; Tsang TK; Xiao J; Wong IOL; Martín-Sánchez M; Leung GM; Cowling BJ; Wu P
Lancet Reg Health West Pac; 2024 Feb; 43():100969. PubMed ID: 38076326
[TBL] [Abstract][Full Text] [Related]
11. Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study.
Wong CKH; Au ICH; Lau KTK; Lau EHY; Cowling BJ; Leung GM
Lancet; 2022 Oct; 400(10359):1213-1222. PubMed ID: 36216007
[TBL] [Abstract][Full Text] [Related]
12. Characteristics, outcome, duration of hospitalization, and cycle threshold of patients with COVID-19 referred to four hospitals in Babol City: a multicenter retrospective observational study on the fourth, fifth, and sixth waves.
Sadeghi F; Halaji M; Shirafkan H; Pournajaf A; Ghorbani H; Babazadeh S; Ezami N; Fallhpour K; Fakhraie F; Gorjinejad S; Amoli SS; Amiri FH; Baghershiroodi M; Ahmadnia Z; Salehi M; Tourani M; Jafarzadeh J; Tabari FS; Ahmadian SR; Mohammadi Abandansari R; Jafarian F; Rouhi S; Zabihollahi A; Mostafanezhad S; Saeedi F; Ebrahimian A; Deldar Z; Zavareh MSH; Bayani M; Broun MB; Shirzad M; Sabbaghi S; Mohammadi M; Rahmani R; Yahyapour Y
BMC Infect Dis; 2024 Jan; 24(1):55. PubMed ID: 38184533
[TBL] [Abstract][Full Text] [Related]
13. Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality.
Kandeel A; Moatasim Y; Fahim M; Bahaaeldin H; El-Shesheny R; Roshdy WH; Kamel MN; Shawky S; Gomaa M; Naguib A; Guindy NE; Deghedy O; Kamel R; Khalifa M; Galal R; Hassany M; Mahmoud G; Kandeil A; Afifi S; Mohsen A; Fattah MA; Kayali G; Ali MA; Abdelghaffar K
BMC Infect Dis; 2023 Aug; 23(1):542. PubMed ID: 37596534
[TBL] [Abstract][Full Text] [Related]
14. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.
Jassat W; Abdool Karim SS; Mudara C; Welch R; Ozougwu L; Groome MJ; Govender N; von Gottberg A; Wolter N; Wolmarans M; Rousseau P; ; Blumberg L; Cohen C
Lancet Glob Health; 2022 Jul; 10(7):e961-e969. PubMed ID: 35597249
[TBL] [Abstract][Full Text] [Related]
15. Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 2022.
Gu H; Ng DYM; Liu GYZ; Cheng SSM; Krishnan P; Chang LDJ; Cheuk SSY; Hui MMY; Lam TTY; Peiris M; Poon LLM
Emerg Infect Dis; 2022 Jun; 28(6):1276-1278. PubMed ID: 35394420
[TBL] [Abstract][Full Text] [Related]
16. Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated hospitalized children: comparison to influenza and parainfluenza infections.
Tso WWY; Kwan MYW; Wang YL; Leung LK; Leung D; Chua GT; Ip P; Fong DYT; Wong WHS; Chan SHS; Chan JFW; Peiris M; Lau YL; Rosa Duque JS
Emerg Microbes Infect; 2022 Dec; 11(1):1742-1750. PubMed ID: 35730665
[TBL] [Abstract][Full Text] [Related]
17. Changes in the intrinsic severity of severe acute respiratory syndrome coronavirus 2 according to the emerging variant: a nationwide study from February 2020 to June 2022, including comparison with vaccinated populations.
Ryu B; Shin E; Kim DH; Lee H; Choi SY; Kim SS; Kim IH; Kim EJ; Lee S; Jeon J; Kwon D; Cho S
BMC Infect Dis; 2024 Jan; 24(1):1. PubMed ID: 38166696
[TBL] [Abstract][Full Text] [Related]
18. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
[TBL] [Abstract][Full Text] [Related]
19. Ancestral SARS-CoV-2 and Omicron BA.5-specific neutralizing antibody and T-cell responses after Omicron bivalent booster vaccination in previously infected and infection-naive individuals.
Mak WA; Visser W; van der Vliet M; Markus HY; Koeleman JGM; Ong DSY
J Med Virol; 2023 Aug; 95(8):e28989. PubMed ID: 37565645
[TBL] [Abstract][Full Text] [Related]
20. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
